Increase Serum Vitamin D Level In Primary Hyperparathyroidism
Abstract
86 years old female a known case of hypertension and osteoporosis, presented in an emergency department with complains of generalized weakness for one month with relative constipation for one week and drowsiness for one day. Arterial blood gas analysis showed hypercapnic respiratory failure and chest radiograph showed bilateral infiltrates. Serum blood test analysis showed increase calcium level which was 14 mg/dl. After further workup, Vitamin D level found to be 130 ng/ml, and Parathyroid level were raised 173 pg/ml and phosphorous level 0.9 mg/dl. She was managed on lines of pneumonia and hypercalcemia secondary to primary hyperthyroidism with unusual finding of raised vitamin D level.
How to Cite This Article
Akhlaq S, Khan SA, Sajid S. Increase Serum Vitamin D Level In Primary Hyperparathyroidism. J Pak Soc Intern Med. 2021;2(3):244–246. doi:10.70302/jpsim.v2i3.2156
Conflict of Interest
All authors declare no competing interests.
Funding
No specific funding was received for this research.
Funder information follows the Crossref Funder Registry standard.
References
- Cerdá D, Peris P, Monegal A, Albaladejo C, de Osaba MM, Surís X, Guañabens N. Aumento de los valores de PTH en la mujer con osteoporosis posmenopáusica. Revista Clínica Española. 2011;211(7):338-43.
- Oltmann SC, Rajaei MH, Sippel RS, Chen H, Schneider DF. Primary hyperparathyroidism across the ages: presentation and outcomes. J Surg Res. 2014;190(1):185‐90.
- Norman J, Goodman A, Politz D. Calcium, parathyroid hormone, and vitamin D in patients with primary hyperparathyroidism: normograms developed from 10,000 cases. Endocr Pract. 2011;17(3):384‐94.
- Bonjour JP, Benoit V, Payen F, Kraenzlin M. Consumption of yogurts fortified in vitamin D and calcium reduces serum parathyroid hormone and markers of bone resorption: a double-blind randomized controlled trial in institutionalized elderly women. J Clin Endocrinol Metab. 2013;98(7):2915‐21.
- Leidig-Bruckner G, Roth HJ, Bruckner T, Lorenz A, Raue F, Frank-Raue K. Are commonly recommended dosages for vitamin D supplementation too low? Vitamin D status and effects of supplementation on serum 25-hydroxyvitamin D levels--an observational study during clinical practice conditions. Osteoporos Int. 2011;22(1):231‐40.
- Coin A, Veronese N, Bolzetta F, De Rui M, Manzato E, Sergi G. Relationship between increased endogenous parathormone levels and bone density in postmenopausal women treated with bisphosphonates. Panminerva Med. 2012;54(4):277‐82.
- Nakamura Y, Uchiyama S, Kamimura M, Ikegami S, Komatsu M, Kato H. Increased Serum 25(OH)D3 Levels in Post-Menopausal Japanese Women with Osteoporosis after 3-Year Bisphosphonate Treatment. Tohoku J Exp Med. 2017;242(3):241‐6.
- Hou Y, Gu K, Xu C, Ding H, Liu C, Tuoheti Y. Dose-Effectiveness Relationships Determining the Efficacy of Ibandronate for Management of Osteoporosis: A Meta-Analysis. Medicine (Baltimore). 2015;94(26):e1007.
Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.